![](/img/cover-not-exists.png)
Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin disease
Mark J. Bishton, Richard J. Lush, Jenny L. Byrne, Nigel H. Russell, Bronwen E. Shaw, Andrew P. HaynesVolume:
136
Year:
2007
Language:
english
Pages:
10
DOI:
10.1111/j.1365-2141.2007.06498.x
File:
PDF, 617 KB
english, 2007